| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.54 | $48.25 $48.25 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $64.33 $59.30 (8%) | 🛒 Add to cart |
| 180 | $0.46 | $96.49 $83.42 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $144.74 $117.60 (19%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $192.98 $152.78 (21%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
digoxin
Digoxin is one of those medications that feels almost timeless in cardiology - we’ve been using it since the 18th century when William Withering first documented the benefits of foxglove extract for dropsy. Yet despite its long history, it remains remarkably relevant in our modern therapeutic arsenal, particularly for managing atrial fibrillation and heart failure when other treatments fall short. What’s fascinating is how this plant-derived cardiac glycoside continues to generate both enthusiasm and caution in equal measure among clinicians.
Aciphex: Potent Acid Suppression for GERD and Ulcer Healing - Evidence-Based Review
Aciphex, known generically as rabeprazole sodium, represents a significant advancement in proton pump inhibitor (PPI) therapy for acid-related gastrointestinal disorders. As a delayed-release tablet, it works by selectively and irreversibly blocking the H+/K+ ATPase enzyme system—the “acid pump”—at the secretory surface of gastric parietal cells. This mechanism provides potent, prolonged suppression of gastric acid secretion, making it a cornerstone in managing conditions like GERD, erosive esophagitis, and Zollinger-Ellison syndrome. Unlike earlier PPIs, Aciphex demonstrates more rapid onset of acid control and maintains consistent pH elevation with once-daily dosing, though individual metabolic variations (particularly CYP2C19 polymorphism) can influence its efficacy.
aldactone
Spironolactone, marketed under the brand name Aldactone, represents one of those foundational medications that every internist ends up having a complicated relationship with. It’s not just another diuretic - it’s a mineralocorticoid receptor antagonist with this fascinating dual life as an anti-androgen. I remember my first month on cardiology service, watching our attending prescribe it for resistant hypertension while our endocrine team was using it for hirsutism. The pharmacy kept sending these puzzled messages asking if we’d confused our patient charts.
aricept
Aricept is the brand name for donepezil hydrochloride, a centrally acting reversible acetylcholinesterase inhibitor. It’s classified as a prescription medication rather than a dietary supplement or medical device, specifically approved for the treatment of Alzheimer’s disease. This molecule works by increasing acetylcholine levels in the brain, which helps mitigate cognitive decline in dementia patients. I’ve prescribed it for nearly two decades now, watching the landscape of dementia treatment evolve around this cornerstone therapy.
Arjuna: Comprehensive Cardioprotective Support for Cardiovascular Health - Evidence-Based Review
Arjuna, derived from the bark of the Terminalia arjuna tree, has been a cornerstone of Ayurvedic cardiology for centuries. Modern research is now validating what traditional practitioners observed—this botanical exhibits remarkable cardioprotective properties, particularly in managing various stages of cardiovascular disease, from early endothelial dysfunction to post-myocardial infarction recovery. 1. Introduction: What is Arjuna? Its Role in Modern Medicine So, what is Arjuna, really? In the clinic, we’re moving beyond seeing it as just an “herbal supplement.
artane
Trihexyphenidyl hydrochloride, an anticholinergic agent available under the brand name Artane among others, represents one of the older pharmacological tools in our neurological arsenal. It’s primarily indicated for the symptomatic management of parkinsonism and drug-induced extrapyramidal reactions. What’s fascinating isn’t just its mechanism—which we’ll explore—but its persistence in clinical practice despite newer alternatives. I’ve watched residents rotate through our movement disorders clinic who initially dismiss Artane as “old-school,” only to discover its particular utility in specific patient populations where other medications fall short.
Azulfidine: Targeted Anti-Inflammatory Therapy for Chronic Autoimmune Conditions - Evidence-Based Review
Sulfasalazine, known commercially as Azulfidine, represents one of those fascinating cases in pharmacotherapy where a drug developed for one purpose finds its most significant application elsewhere. Originally synthesized in the 1930s by combining sulfapyridine and salicylate molecules, researchers hoped to create a superior antibiotic for rheumatic fever treatment. The antibacterial properties proved underwhelming, but clinicians noticed something remarkable - patients with coexisting inflammatory bowel disease showed dramatic improvement in their gastrointestinal symptoms.
Betapace: Advanced Rhythm Control for Ventricular Arrhythmias - Evidence-Based Review
Product Description Betapace represents a significant advancement in cardiac rhythm management, specifically developed for patients with life-threatening ventricular arrhythmias who haven’t responded to conventional antiarrhythmics. This class III antiarrhythmic agent, with its unique dual beta-adrenergic blocking properties, has fundamentally changed how we approach difficult-to-treat arrhythmia cases in clinical practice. I remember when we first started using Betapace back in the late 90s - we had this patient, Martin, a 58-year-old with recurrent ventricular tachycardia despite amiodarone therapy.
Betoptic: Effective Intraocular Pressure Control for Glaucoma - Evidence-Based Review
Betoptic, known generically as betaxolol hydrochloride, represents a cornerstone in ophthalmologic therapy as a selective beta-1 adrenergic receptor blocking agent. It’s formulated specifically for ocular use to manage intraocular pressure (IOP). Unlike many systemic beta-blockers, its development focused on local administration to minimize systemic absorption while maximizing therapeutic effect directly at the site of action—the eye. This approach significantly reduces the risk of pulmonary and cardiovascular side effects commonly associated with non-selective beta-blockers, making it a preferred choice for patients with comorbid conditions like asthma or COPD.